Lymphoma Clinical Trials
There are 35 registered clinical trials for Lymphoma in the TrialLens index.
Trials (35)
- Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma Phase 2 · Institut Curie
- Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Phase 2 · Alliance for Clinical Trials in Oncology
- Supportive Oncology Care At Home RCT N/A · Massachusetts General Hospital
- Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers N/A · Rutgers, The State University of New Jersey
- Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Phase 3 · Jonsson Comprehensive Cancer Center
- Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies N/A · M.D. Anderson Cancer Center
- Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma Phase 4 · University of Miami
- Phase I Study of Sequential Cord Blood Transplants Phase 1 · Massachusetts General Hospital
- Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma N/A · St Stephens Aids Trust
- Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer Phase 1 · Roswell Park Cancer Institute
- AMG 319 Lymphoid Malignancy FIH Phase 1 · Amgen
- Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation N/A · Armando Santoro, MD
- CDDO to Treat Solid Tumors and Lymphomas Phase 1 · National Cancer Institute (NCI)
- ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL N/A · Hua-Jay J Cherng, MD
- The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies Phase 1 · Memorial Sloan Kettering Cancer Center
- Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders Phase 2 · City of Hope Medical Center
- Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood Phase 1 · M.D. Anderson Cancer Center
- Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma Phase 2 · OHSU Knight Cancer Institute
- Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer N/A · Children's Oncology Group
- Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer Phase 2 · Memorial Sloan Kettering Cancer Center
- Metabolic Syndrome in Childhood Cancer Survivors N/A · University of Minnesota
- Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment Phase 1 · Swiss Cancer Institute
- MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma N/A · Guangxi Medical University
- A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL) Phase 1 · MedImmune LLC
- A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy Phase 2 · National Cancer Institute (NCI)
- Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas Phase 1 · Symphogen A/S
- RAT-HEMATO : Return to Work After Malignant Hemopathy N/A · University Hospital, Angers
- S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Phase 2 · SWOG Cancer Research Network
- Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma Phase 2 · Case Comprehensive Cancer Center
- Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma N/A · European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma
- Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) Phase 3 · M.D. Anderson Cancer Center
- Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma Phase 3 · Commissie Voor Klinisch Toegepast Onderzoek
- Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors Phase 1 · Pediatric Brain Tumor Consortium
- Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen Phase 2 · OHSU Knight Cancer Institute
- ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma Phase 1 · Memorial Sloan Kettering Cancer Center
Related landscapes
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.